The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.

By Y. Herishanu, P. Pérez-Galán, Delong Liu, A. Biancotto, S. Pittaluga, B. Vire, Federica Gibellini, N. Njuguna, Elinor Lee, L. Stennett and 14 more. Blood, 2011

868 citations recorded by the source corpus.

Subfields: Genetics, Molecular Biology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/6f2f6a1b807f759d361f99f6e99a1aa46cd8131a

Citations in the corpus

• Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia (2014, neutral): “at Risk (events) Idelalisib Placebo 110 (0) 110 (0) 88 (1) 76 (8) 55 (2) 43 (9) 40 (2) 25 (11) 31 (4) 18 (11) 16 (4) 8 (12) 7 (4) 2 (12) 4 (4) 1 (12) 0 (4) 0 (12) 10 12 Idelalisib plus rituximab”